Avastin versus Lucentis: ethical issues in treatment of age-related macular degeneration
- PMID: 18046218
- DOI: 10.1097/IAE.0b013e31815e9322
Avastin versus Lucentis: ethical issues in treatment of age-related macular degeneration
Comment in
-
Cheap shots and pricey propositions: evidence, disclosure, and treatment of age-related macular degeneration.Retina. 2007 Nov-Dec;27(9):1166-7. doi: 10.1097/IAE.0b013e31815ee57e. Retina. 2007. PMID: 18046219 No abstract available.
-
Avastin versus Lucentis: ethical issues.Retina. 2008 Jul-Aug;28(7):1024-5; author reply 1025. doi: 10.1097/IAE.0b013e318176de5f. Retina. 2008. PMID: 18698312 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
